Agios Pharma (AGIO) PT Raised to $44 at RBC Capital
RBC Capital analyst Kennen MacKay raised the price target on Agios Pharma (NASDAQ: AGIO) to $44.00 (from $42.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)